LGC's Genomics Division has signed a memorandum of understanding (MOU) with Chinese health management expert Personal Health to establish a genotyping research partnership. The partnership will see Personal Health become the first “LGC Douglas Scientific® High-Throughput Genotyping Demo Lab” in China.Read More
The BiosearchTech Blog
The 25th annual International Plant & Animal Genome (PAG) conference is right around the corner and LGC will be in San Diego, CA showcasing our integrated offerings for a wide variety of genomics workflow solutions. From SNP discovery, to routine screening - we harness the power and flexibility of our integrated tools to enable breeding programmes.Read More
For DNA Technology’s existing customers, don’t fret! The online ordering process will remain the same, as will the team assisting you. BHQ® probes, BHQplus® probes, and custom oligos will continue to be offered at the facility in Denmark. This facility is DS/EN ISO 9001:2008 compliant and the products are intended for research and development use. For more consequential assays, GMP manufacturing is also available.Read More
We are pleased to announce that LGC Biosearch Technologies’ released a new and improved biosearchtech.com. Thank you to all our web visitors who’ve left feedback over the years. With your suggestions, we developed and consolidated features to better address your needs. Check out these top four improvements:Read More
At this year’s 24th annual Plant & Animal Genome (PAG) conference, LGC Biosearch Technologies hosted a symposium titled “Latest advancements in genotyping technologies for molecular breeding.” This symposium featured key AgBio opinion leaders and industry professionals to discuss about recent developments within the field of marker assisted selection. The slides and audio from these presentations are now available online for your immediate viewing. The presenters and their topics are as follows:Read More
The summer promotion is back! For the month of July, use your Biosearchtech.com account to place an order and take 5% off your online purchase. This is a great opportunity to try another dye for your BHQ® probe (be sure to check out our interactive spectral overlay tool), or pick up an off-the-shelf Stellaris® ShipReady Assay. Just enter promo code SUMMER15* during checkout to receive the discount.Read More
Biosearch will be observing these upcoming holidays and will be closing our US facilities on the following dates:
- Christmas: 12/23 - 12/25
- New Year's: 12/31 - 1/1
Please take into account these breaks in operation when ordering. Orders placed during the dates listed above will be processed when we return. We want to make this holiday season enjoyable for everyone.
Thank you for your patience. Happy Holidays!
Biosearch Technologies, Inc. (Biosearch), a leading supplier of sophisticated oligonucleotide components to the rapidly growing molecular diagnostics industry announced today that it has acquired exclusive worldwide rights to turboFISH technology - A Method for Rapid Single Molecule RNA FISH. With this turboFISH license, Biosearch maintains exclusive access to continuing Stellaris® RNA FISH based inventions from Rutgers, The State University of New Jersey.
Biosearch has acquired a majority stake in LightSpeed Genomics, Inc. (LSG), a Santa Clara, California-based company developing an innovative optical detection solution for the life science and diagnostics industry based on its proprietary Synthetic Aperture Optics™ (SAO™) technology. Biosearch and LSG are collaborators on the development of StellarVision™, a next generation gene expression platform optimized to work seamlessly with Biosearch’s Stellaris® RNA FISH assays to detect and quantify single molecule RNA targets within individual cells.
Biosearch Technologies, Inc. (Biosearch), a leader in the development and manufacture of GMP grade oligonucleotides, announced today the relocation of its GMP manufacturing process into a new, state-of-the-art GMP production facility in Novato, California. The 30,000 square foot facility was developed to further expand processes and controls relevant to medical device and molecular diagnostic customers.